---
title: "Vaccine Prospectus: National Immunisation Programme and vaccine products"
ocid: "ocds-h6vhtk-06f509"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f509"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06f509.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06f509.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "UK Health Security Agency"
published: "2026-09-08"
---

# Vaccine Prospectus: National Immunisation Programme and vaccine products

Buyer: UK Health Security Agency  
Current stage: Planning  
OCID: ocds-h6vhtk-06f509

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f509)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06f509.json)

## Summary

The UK Health Security Agency (UKHSA), acting for the Secretary of State for Health and Social Care, is exploring vaccine products and activity across the national immunisation programme. The work covers the full vaccine pathway: facilitating innovation, supporting the development and deployment of safe and effective vaccines, and enabling reliable procurement, storage and distribution. It also aims to increase vaccine uptake and reduce infectious disease. This is a goods requirement for vaccines, with activity relevant to suppliers operating in the vaccine and wider life sciences sector. UKHSA’s Vaccine Prospectus sets out its programmes, policy objectives, approach to working with industry and potential future ways to work with the agency. The relevant public-sector customer is UKHSA in London.

This procurement is at the planning stage and is not an invitation to tender. UKHSA has published an intention to engage organisations across industry, academia, research institutions and the wider life sciences sector to increase awareness and encourage discussion. The expected procurement approach has not been settled in the available process information. An engagement milestone is scheduled for 1 January 2030, and the planned contract period is shown as 1 January 2030 to 2 January 2030. These are the buyer’s indicative expectations rather than a tender deadline. The process concerns one planned lot for vaccine products. UKHSA states that publication of the Vaccine Prospectus does not commit it to undertake procurement activity.

This will suit vaccine manufacturers, developers, research organisations, academic institutions and other life sciences businesses with relevant capabilities across the vaccine pathway. Potentially relevant strengths include vaccine research and development, clinical or other evaluation work, regulatory and safety expertise, manufacturing, supply-chain management, storage, distribution and population-level immunisation support. Organisations able to contribute to innovation while meeting the requirements for safe and effective vaccines may be well placed to engage. The prospectus is also relevant to businesses interested in helping the public sector improve vaccine uptake and reduce infectious disease. It provides an early opportunity to understand UKHSA’s priorities and prepare for possible future procurement or collaboration, rather than a contract that can be bid for now.

## Notice

Improving health outcomes through vaccines is a priority for the UK Health Security Agency (UKHSA). We aim to use UKHSA's capabilities across the full vaccine pathway to facilitate innovation and support the development and deployment of safe and effective vaccines, ensure the reliable and timely procurement, storage and distribution of vaccines, and drive increased uptake among the population to reduce the burden of infectious disease. UKHSA published a Vaccine Prospectus in August 2026, which sets out the work that UKHSA and the wider health family do to sustain and grow the UK's world-leading role in immunisation. It details the scope of our programmes, our policy objectives, how we work with industry, and forthcoming opportunities to work with us. The publication can be accessed here: https://www.gov.uk/government/publications/vaccine-prospectus-national-immunisation-programme-and-vaccine-products

### Planning Information

This notice does not relate to a specific procurement exercise. No contract opportunity is being advertised through this notice, and publication of the Prospectus does not commit UKHSA to undertake any procurement activity.
UKHSA is inviting organisations across industry, academia, research institutions and the wider life sciences sector to read the Prospectus. The purpose of this engagement is to increase market awareness and encourage engagement with relevant stakeholders. 
To reach the right people at the agency, you can contact UKHSA using the following:
Industry enquiries: industry@ukhsa.gov.uk
Potential customers, including enquiries about the Vaccine Development and Evaluation Centre (VDEC): business@ukhsa.gov.uk

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/085109-2026 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | Not specified |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 8 Sep 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | Not specified |
| Contract period | 1 Jan 2030 - 2 Jan 2030 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | UK Health Security Agency |
| Locality | LONDON |
| Postcode area | East London |
| Postcode | E14 4PU |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI42 Tower Hamlets |
| Local authority | Tower Hamlets |
| Electoral ward | Canary Wharf |
| Westminster constituency | Poplar and Limehouse |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33651600 - Vaccines

## Release History

- 8 Sep 2026 at 17:19 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/085109-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/085109-2026
  8th September 2026 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://www.gov.uk/government/organisations/uk-health-security-agency
- https://www.gov.uk/government/publications/vaccine-prospectus-national-immunisation-programme-and-vaccine-products
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06f509. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06f509.json.